Company page
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. is a public company traded under the ticker PHAT in the American market. The company has a market capitalization of approximately $827 million. Phathom focuses on developing innovative treatments for gastrointestinal diseases.
- Ticker
- PHAT:NASDAQ
- Asset type
- Stock
- Market cap
- $827.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD